HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Thromboprophylaxis for cerebrovascular disorders: acetylsalicylic acid remains the cornerstone].

Abstract
Antithrombotic medication plays a key role in the treatmentand secondary prophylaxis of atherothrombotic conditions. Numerous studies have found that acetylsalicylic acid is effective in reducing the incidence of (recurrent) acute vascular events, such as myocardial infarction or ischaemic stroke. For coronary atherothrombosis, anticoagulation with vitamin K antagonists was shown to be slightly superior to acetylsalicylic acid in high-risk patients. Two major trials, the 'Stroke prevention in reversible ischemia trial' (SPIRIT) and the 'European/Australasian stroke prevention in reversible ischaemia trial' (ESPRIT), showed that vitamin K antagonists were more effective than placebo in the prevention of ischaemic stroke, but the favourable effect was completely offset by a higher incidence of major bleeding (including intracerebral bleeding) in patients using vitamin K antagonists. In the ESPRIT trial, the combination of acetylsalicylic acid and dipyridamole provided a modest benefit over acetylsalicylic acid alone in the prevention of (recurrent) ischaemic stroke.
AuthorsM Levi
JournalNederlands tijdschrift voor geneeskunde (Ned Tijdschr Geneeskd) Vol. 152 Issue 8 Pg. 423-5 (Feb 23 2008) ISSN: 0028-2162 [Print] Netherlands
Vernacular TitleTromboseprofylaxe bij cerebrovasculaire aandoeningen: de hoeksteen blijft acetylsalicylzuur.
PMID18361189 (Publication Type: Comment, English Abstract, Journal Article)
Chemical References
  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Vitamin K
  • Aspirin
Topics
  • Aspirin (therapeutic use)
  • Cerebrovascular Disorders (prevention & control)
  • Fibrinolytic Agents (therapeutic use)
  • Humans
  • Platelet Aggregation Inhibitors (therapeutic use)
  • Recurrence
  • Treatment Outcome
  • Vitamin K (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: